IRS-2 deubiquitination by USP9X maintains anchorage-independent cell growth via Erk1/2 activation in prostate carcinoma cell line.
Furuta H, Yoshihara H, Fukushima T, Yoneyama Y, Ito A, Worrall C, Girnita A, Girnita L, Yoshida M, Asano T, Komada M, Kataoka N, Chida K, Hakuno F, Takahashi SI.
Furuta H, et al. Among authors: yoneyama y.
Oncotarget. 2018 Sep 21;9(74):33871-33883. doi: 10.18632/oncotarget.26049. eCollection 2018 Sep 21.
Oncotarget. 2018.
PMID: 30338032
Free PMC article.